Human interleukin (IL)-17 cytokine-binding peptides
CO20260009128A2Pending Publication Date: 2026-06-30PROTAGONIST THERAPEUTICS INC
Patent Information
- Authority / Receiving Office
- CO · CO
- Patent Type
- Applications
- Current Assignee / Owner
- PROTAGONIST THERAPEUTICS INC
- Filing Date
- 2026-06-19
- Publication Date
- 2026-06-30
Abstract
This description provides peptide compounds that inhibit the human cytokine IL-17. This description also provides pharmaceutical compositions that include these peptide compounds. Furthermore, this description also provides methods of using the peptide compounds, such as methods for treating or preventing diseases, conditions, or disorders mediated by or associated with IL-17.
Need to check novelty before this filing date? Find Prior Art